Zacks.com on MSN2d
VIR Stock Up on Early Safety & Efficacy Data on Two Cancer Candidates
Vir Biotechnology, Inc. VIR announced encouraging initial data from a phase I study that evaluated its investigational ...
Prostate cancer screening breakthrough could cut time of test to twenty minutes
New prostate cancer imaging shows ‘extremely encouraging’ results in trials - It is hoped the new technology will cut waiting ...